<--- Back to Details
First PageDocument Content
Immunology / Immune system / T cells / Interleukins / Programmed cell death protein 1 / PD-L1 / Immunotherapy / CD8 / IMP321 / Interleukin 21
Date: 2015-12-11 00:15:27
Immunology
Immune system
T cells
Interleukins
Programmed cell death protein 1
PD-L1
Immunotherapy
CD8
IMP321
Interleukin 21

Microsoft PowerPoint - AM0010-001 TIP Mayfinal

Add to Reading List

Source URL: www.armobio.com

Download Document from Source Website

File Size: 110,88 KB

Share Document on Facebook

Similar Documents

# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi

DocID: 1vdls - View Document

Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx

DocID: 1uTyz - View Document

April 18, 2018 Torii Pharmaceutical Co., Ltd. Price Listing on the NHI Reimbursement List and Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar Poll

DocID: 1uM8x - View Document

第42回 日本免疫学会学術集会 クリニカルセミナー 2 Sublingual immunotherapy for Japanese cedar pollinosis

DocID: 1untY - View Document

President of ORPHEUS Robert Adam Harris Professor in Immunotherapy in Neuroinflammation Karolinska Institutet Personal details:

DocID: 1u6T9 - View Document